FIELD: biotechnology.
SUBSTANCE: present invention relates to the field of biotechnology, specifically to recombinant protein for producing neutralizing antibodies against one or several growth factors. An artificially constructed protein molecule, according to the present invention, includes several fragments interconnected by a short peptide linker, selected from immunogen peptide and neutralizing domain of one or more human growth factors, which are mediators of cell proliferation in different cancer types.
EFFECT: invention can be used in the production of vaccines for immunotherapy of tumor diseases.
15 cl, 44 dwg, 14 ex
| Title | Year | Author | Number |
|---|---|---|---|
| RECOMBINANT PROTEINS AND THEIR THERAPEUTIC USES | 2012 |
|
RU2650574C2 |
| SELF-ASSEMBLY SYNTHETIC PROTEINS | 2014 |
|
RU2801230C2 |
| SELF-ASSEMBLING SYNTHETIC PROTEINS | 2014 |
|
RU2747857C2 |
| THERAPEUTIC COMPOSITION FOR REDUCING RESISTANCE TO TYROSINE KINASE INHIBITORS | 2016 |
|
RU2735493C2 |
| COMBINATIONS OF GROWTH-REGULATING FACTORS AND HORMONES FOR NEOPLASIA TREATMENT | 2003 |
|
RU2321422C2 |
| RECEPTOR ANTAGONISTS FOR TREATING METASTATIC CANCER | 2009 |
|
RU2455026C2 |
| BISPECIFIC BINDING AGENTS FOR MODULATING BIOLOGICAL ACTIVITY | 2005 |
|
RU2433831C2 |
| PDGFRα ANTIBODIES FOR TREATING SECONDARY BONE TUMOUR | 2006 |
|
RU2502523C2 |
| HIGH-AFFINITY ANTI-CD3 ANTIBODIES AND METHODS FOR PRODUCTION AND USE THEREOF | 2020 |
|
RU2831840C2 |
| METHODS OF PREDICTING RESPONSE OF TRIPLE NEGATIVE MAMMARY GLAND CANCER TO THERAPY | 2011 |
|
RU2558931C2 |
